Home » Topics » Regulatory

Regulatory
RSS

Zambon claims (S)-ibuprofen composition

May 3, 1996

Droxidopa studied in patients with chronic pain

May 3, 1996

V-411 approved for marketing in China

April 26, 1996

Pulmonary insulin enters phase II

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

Update on terfenadine carboxylate progress

April 26, 1996

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...